FDLI: Biologic and Biosimilar Litigation and IP Rights

This Month
Webinar (ET)

Neil P. Di Spirito, Member of the Firm, will moderate, "Biologic and Biosimilar Litigation and IP Rights," a webinar hosted by the Food and Drug Law Institute (FDLI).

As there continues to be an increase in biologic and biosimilar product applications and approvals, new lawsuits and judicial decisions area also on the rise. This webinar will provide updates and trends in biologic and biosimilar litigation, including lawsuits by biosimilar applicants against biologic sponsors, lawsuits between biologic sponsors, and lawsuits between biosimilar manufacturers. Speakers will also discuss recent case law related to patent term exclusivity, United States Patent and Trademark Office (USPTO) proceedings, and important recent and pending Courts of Appeal decisions.

For more information and to register, please visit FDLI.org.